OREXIGEN

Serial Number 78960760
Registration 3396807
800

Registration Progress

Application Filed
Aug 25, 2006
Under Examination
Approved for Publication
Published for Opposition
Registered
Mar 11, 2008

Basic Information

Serial Number
78960760
Registration Number
3396807
Filing Date
August 25, 2006
Registration Date
March 11, 2008
Renewal Date
March 11, 2018
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Mar 26, 2018
Registration
Registered
Classes
005 016 044

Rights Holder

NALPROPION PHARMACEUTICALS LLC

16
Address
155 Franklin Road, Suite 450
Brentwood, TN 37027

Ownership History

Orexigen Therapeutics, Inc.

Original Applicant
03
San Diego, CA

Orexigen Therapeutics, Inc.

Original Registrant
03
La Jolla, CA

NALPROPION PHARMACEUTICALS, INC.

New Owner After Registration #1
03
MORRISTOWN, NJ

NALPROPION PHARMACEUTICALS LLC

New Owner After Registration #2
16
Brentwood, TN

Legal Representation

Attorney
Andrew N. Spivak

USPTO Deadlines

Next Deadline
976 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2008-03-11)
Due Date
March 11, 2028
Grace Period Ends
September 11, 2028

Application History

43 events
Date Code Type Description
Jul 27, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 27, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 27, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 27, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 27, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 23, 2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 8, 2018 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 6, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 6, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 26, 2018 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Mar 26, 2018 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Mar 26, 2018 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Mar 22, 2018 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 9, 2018 E89R I TEAS SECTION 8 & 9 RECEIVED
Mar 11, 2017 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Mar 23, 2016 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 25, 2014 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 25, 2014 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED
Sep 25, 2014 NAS8 E NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Sep 10, 2014 ES8R I TEAS SECTION 8 RECEIVED
May 20, 2008 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 20, 2008 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 11, 2008 R.SR A REGISTERED-SUPPLEMENTAL REGISTER
Feb 5, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 31, 2008 IUAA P USE AMENDMENT ACCEPTED
Jan 31, 2008 CNTA O APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jan 26, 2008 IUAF S USE AMENDMENT FILED
Jan 26, 2008 AUPC I AMENDMENT TO USE PROCESSING COMPLETE
Jan 25, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 25, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2008 EAAU I TEAS AMENDMENT OF USE RECEIVED
Jul 25, 2007 CNRT R NON-FINAL ACTION WRITTEN
Jul 25, 2007 GNRT O NON-FINAL ACTION E-MAILED
Jul 25, 2007 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 19, 2007 ALIE A ASSIGNED TO LIE
Jul 19, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2007 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 2, 2007 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 20, 2007 DOCK D ASSIGNED TO EXAMINER
Jan 20, 2007 CNRT R NON-FINAL ACTION WRITTEN
Jan 20, 2007 GNRT F NON-FINAL ACTION E-MAILED
Aug 30, 2006 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
First Use Anywhere: Oct 2, 2007
First Use in Commerce: Oct 2, 2007
Class 016
PRINTED INSTRUCTIONAL, EDUCATIONAL AND TEACHING MATERIALS IN THE FIELD OF TREATMENT AND MANAGEMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
First Use Anywhere: Dec 5, 2007
First Use in Commerce: Dec 5, 2007
Class 044
PROVIDING MEDICAL INFORMATION IN THE FIELD OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
First Use Anywhere: Mar 7, 2006
First Use in Commerce: Mar 7, 2006

Classification

International Classes
005 016 044